大酶K+CD8T细胞通过向微质细胞来减缓 tauopathy 的进展
Hannah D Mason1, Yvonne L Latour1, Christopher T Boughter2
1Viral Immunology and Intravital Imaging Section, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD, USA.
Nature immunology
|June 24, 2025
概括
有益的免疫细胞叫做granzyme K (GZMK) + CD8+ T细胞通过准受损的微质来减缓神经退行性病. 这些细胞对于控制酸化 (pTau) 传播和神经衰退至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
背景情况:
- 神经退行性疾病涉及复杂的免疫反应.
- 了解病的有益免疫机制至关重要.
研究的目的:
- 在小鼠和人类的病发育过程中识别有益的免疫压力.
- 为了研究CD8+ T细胞在病进展中的作用.
主要方法:
- 使用表达突变人类tau的小鼠.
- 分析了微质细胞和CD8+ T细胞的相互作用.
- 检查了来自各种神经退行性疾病的人类大脑病变.
- 研究了免疫检查点阻塞 (TIGIT,PD-1) 和CD8+T细胞删除的影响.
主要成果:
- 微质最初通过控制酸化 (pTau) 的传播来减缓病变.
- 随着时间的推移,微质细胞成为 CD8+ T 细胞准的抗原呈现细胞.
- 表达大酶K (GZMK) 的CD8+T细胞将GZMK沉积在微质上.
- 免疫检查点封锁 (TIGIT,PD-1) 恶化了疾病的进展.
- 在人类病变中发现了GZMK+ CD8+ T细胞.
- CD8+ T细胞的删除加速了pTau的传播和神经衰退.
结论:
- GZMK+ CD8+ T 细胞是病的关键特征.
- 这些T细胞通过准处于困境的微质细胞来发挥保护作用.
- 准GZMK+ CD8+ T细胞可能为病症提供治疗策略.
更多相关视频
相关概念视频
Cytotoxic T Cells-mediated Immune Response
2.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.5K
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265


